Fangqian Yin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Fangqian Yin has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
- Ke-Rang Wang
College of Chemistry and Materials Science, Key Laboratory of Medicinal Chemistry and Molecular Diagnosis (Ministry of Education), State Key Laboratory of New Pharmaceutical Preparations and Excipients, Key Laboratory of Chemical Biology of Hebei Province, Hebei University, Baoding, 071002, China
6 shared publications Tingchun Zhu
Hebei Key Laboratory of Heterocyclic Compounds, Handan University, Handan, 056005, Hebei province, PR China
3 shared publicationsChao-Na An
College of Chemistry and Materials Science, State Key Laboratory of New Pharmaceutical Preparations and Excipients, Key Laboratory of Medicinal Chemistry and Molecular Diagnosis (Ministry of Education), Key Laboratory of Chemical Biology of Hebei Province, Hebei University, Baoding, 071002, P. R. China
2 shared publications- Dong-Sheng Guo
College of Chemistry State Key Laboratory of Medicinal Chemical Biology Key Laboratory of Functional Polymer Materials (Ministry of Education) Nankai University Tianjin China
2 shared publications Gao-Juan Lin
College of Chemistry and Materials Science, Key Laboratory of Medicinal Chemistry and Molecular Diagnosis (Ministry of Education), State Key Laboratory of New Pharmaceutical Preparations and Excipients, Key Laboratory of Chemical Biology of Hebei Province, Hebei University, Baoding, 071002, China
2 shared publications- Jing Liu
College of Veterinary Medicine, Hebei Agricultural University, Baoding Hebei 071000, China
2 shared publications
Latest Publications
Low‐Temperature Photothermal Antibacterial Activity and Wound Healing Promotion Mediated by Controlled Nitric Oxide Release
Bacterial infections pose a severe global threat, and while antibiotics are the primary clinical treatment, their widespread misuse has led to increasing drug resistance, making the development of alternative therapies an urgent task. Photothermal antibacterial treatment is a promising approach, but the high temperatures required can damage surrounding tissues. Low‐temperature photothermal therapy offers a safer solution but often suffers from reduced efficacy. In this study, we designed PMI‐NOP , a photothermal agent capable of light‐triggered NO release, to achieve effective low‐temperature antibacterial treatment against both standard and multidrug‐resistant P. aeruginosa . In vitro and in vivo experiments demonstrated that PMI‐NOP effectively eliminated clinically isolated drug‐resistant P. aeruginosa at 45°C, achieving comparable efficacy to conventional 55°C treatment while significantly reducing inflammation and heat shock response, thereby minimizing thermal damage to surrounding tissue. These findings showed that combining controlled NO release with low‐temperature photothermal treatment provides a safer and highly effective alternative to treat bacterial infections.
Low‐Temperature Photothermal Antibacterial Activity and Wound Healing Promotion Mediated by Controlled Nitric Oxide Release
Bacterial infections pose a severe global threat, and while antibiotics are the primary clinical treatment, their widespread misuse has led to increasing drug resistance, making the development of alternative therapies an urgent task. Photothermal antibacterial treatment is a promising approach, but the high temperatures required can damage surrounding tissues. Low‐temperature photothermal therapy offers a safer solution but often suffers from reduced efficacy. In this study, we designed PMI‐NOP , a photothermal agent capable of light‐triggered NO release, to achieve effective low‐temperature antibacterial treatment against both standard and multidrug‐resistant P. aeruginosa . In vitro and in vivo experiments demonstrated that PMI‐NOP effectively eliminated clinically isolated drug‐resistant P. aeruginosa at 45°C, achieving comparable efficacy to conventional 55°C treatment while significantly reducing inflammation and heat shock response, thereby minimizing thermal damage to surrounding tissue. These findings showed that combining controlled NO release with low‐temperature photothermal treatment provides a safer and highly effective alternative to treat bacterial infections.
- Open Access
- 1 January 2026
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 17 (31) , 15117-15125
In situ glycosylation-directed H-aggregation of Type I photosensitizers for synergistic biofilm eradication and promoting diabetic wound healing
Glycosylated NBS-Lac forms H-aggregates to enhance charge transfer and ISC, boosting O 2 ˙ − production. This hypoxia-active photosensitizer achieves potent antibiofilm activity and accelerates diabetic wound healing with excellent biosafety.
- 1 January 2026
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 17 (31) , 15117-15125
Open AccessIn situ glycosylation-directed H-aggregation of Type I photosensitizers for synergistic biofilm eradication and promoting diabetic wound healing
Glycosylated NBS-Lac forms H-aggregates to enhance charge transfer and ISC, boosting O 2 ˙ − production. This hypoxia-active photosensitizer achieves potent antibiofilm activity and accelerates diabetic wound healing with excellent biosafety.
- 1 January 2026
- Published by Royal Society of Chemistry (RSC) in RSC Medicinal Chemistry
- Vol. 17 (8) , 3554-3567
Research process of iminosugars in glycosidase inhibition and hypoglycemic activity
Multivalent effect or glycocluster effect is a natural phenomenon, especially for the carbohydrate-protein interactions.Multivalent glycoclusters have been widely studied, which show significantly stronger binding interactions with proteins compared with the...
- 1 January 2026
- Published by Royal Society of Chemistry (RSC) in RSC Medicinal Chemistry
- Vol. 17 (8) , 3554-3567
Research process of iminosugars in glycosidase inhibition and hypoglycemic activity
Multivalent effect or glycocluster effect is a natural phenomenon, especially for the carbohydrate-protein interactions.Multivalent glycoclusters have been widely studied, which show significantly stronger binding interactions with proteins compared with the...
- Open Access
- 1 January 2026
- Published by American Dairy Science Association in Journal of Dairy Science
- Vol. 109 (1) , 68-82
Detection of 13 quinolones in milk by a Pseudomonas quinolone signaling receptor-based competitive chemiluminescence assay
With the widespread usage of quinolones (QN) in treating infectious diseases on farms, their notable toxicity and the emergence of resistance have raised increasing concerns in public health and environmental fields. Here, we report a competitive binding chemiluminescence assay (CLA) that enables the detection of 13 QN in milk. We deploy a specific binding biocomponent, the Pseudomonas quinolone signaling receptor (PqsR), to facilitate sensitivity and group-specificity toward QN. Through structural alignment, molecular docking, and surface plasmon resonance method, we elucidate the mechanism of molecular interaction and the high affinity between PqsR and QN. The PqsR-based CLA demonstrates an ultralow limit of detection for 13 QN ranging from 1.91 × 10-3 to 6.18 × 10-2 ng·mL-1, which complies with the maximum residue limit of QN established in China, the European Union, and the United States. Furthermore, it illustrates spiked recoveries in milk matrices ranging from 70.2% to 97.3%, with coefficients of variation below 12.8%. These findings highlight the potential of the PqsR-based CLA for high-throughput, rapid, and sensitive detection of multi-QN. Exploring the commonality of interactions qualitatively and quantitatively from a structural perspective may pave the way for the discovery of novel group-specific binding materials.
- 1 January 2026
- Published by American Dairy Science Association in Journal of Dairy Science
- Vol. 109 (1) , 68-82
Open AccessDetection of 13 quinolones in milk by a Pseudomonas quinolone signaling receptor-based competitive chemiluminescence assay
With the widespread usage of quinolones (QN) in treating infectious diseases on farms, their notable toxicity and the emergence of resistance have raised increasing concerns in public health and environmental fields. Here, we report a competitive binding chemiluminescence assay (CLA) that enables the detection of 13 QN in milk. We deploy a specific binding biocomponent, the Pseudomonas quinolone signaling receptor (PqsR), to facilitate sensitivity and group-specificity toward QN. Through structural alignment, molecular docking, and surface plasmon resonance method, we elucidate the mechanism of molecular interaction and the high affinity between PqsR and QN. The PqsR-based CLA demonstrates an ultralow limit of detection for 13 QN ranging from 1.91 × 10-3 to 6.18 × 10-2 ng·mL-1, which complies with the maximum residue limit of QN established in China, the European Union, and the United States. Furthermore, it illustrates spiked recoveries in milk matrices ranging from 70.2% to 97.3%, with coefficients of variation below 12.8%. These findings highlight the potential of the PqsR-based CLA for high-throughput, rapid, and sensitive detection of multi-QN. Exploring the commonality of interactions qualitatively and quantitatively from a structural perspective may pave the way for the discovery of novel group-specific binding materials.
- 18 November 2025
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 68 (22) , 24456-24468
Enhanced Antitumor Efficacy and Reduced Myelosuppression by a Supramolecular Complex Composed of Azocalix[4]arene and Sunitinib
Antiangiogenic therapy, which inhibits tumor growth by blocking oxygen and nutrition supply, represents a promising strategy for antineoplastic therapy. However, the widespread biodistribution of antiangiogenic agents often leads to off-target toxicities, including hematotoxicity and myelosuppression. In this study, we demonstrated that the sunitinib@mannose-modified azocalix[4]arene (ST@ManAC4A) complex exhibited favorable tumor-targeting capabilities, hypoxia-responsive drug release, and effective accumulation at the tumor site, thus enhancing antiproliferative efficacy while alleviating thrombocytopenia and myelosuppression. The complex exhibited robust antitumor activity in both cellular and in vivo assays. Additionally, histopathological, immunohistochemical, and bone marrow analyses demonstrated that ST@ManAC4A enhanced antiproliferation, apoptosis, and antiangiogenesis while alleviating thrombocytopenia and platelet-related myelosuppression. These findings underscore the potential of the mannose-modified supramolecular host-guest complex as a versatile form for improving chemotherapy outcomes. By enabling efficient drug loading and precision targeting, this approach offers a promising strategy to enhance therapeutic efficacy while minimizing off-target toxicities, addressing a critical challenge in cancer treatment.
- 18 November 2025
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 68 (22) , 24456-24468
Enhanced Antitumor Efficacy and Reduced Myelosuppression by a Supramolecular Complex Composed of Azocalix[4]arene and Sunitinib
Antiangiogenic therapy, which inhibits tumor growth by blocking oxygen and nutrition supply, represents a promising strategy for antineoplastic therapy. However, the widespread biodistribution of antiangiogenic agents often leads to off-target toxicities, including hematotoxicity and myelosuppression. In this study, we demonstrated that the sunitinib@mannose-modified azocalix[4]arene (ST@ManAC4A) complex exhibited favorable tumor-targeting capabilities, hypoxia-responsive drug release, and effective accumulation at the tumor site, thus enhancing antiproliferative efficacy while alleviating thrombocytopenia and myelosuppression. The complex exhibited robust antitumor activity in both cellular and in vivo assays. Additionally, histopathological, immunohistochemical, and bone marrow analyses demonstrated that ST@ManAC4A enhanced antiproliferation, apoptosis, and antiangiogenesis while alleviating thrombocytopenia and platelet-related myelosuppression. These findings underscore the potential of the mannose-modified supramolecular host-guest complex as a versatile form for improving chemotherapy outcomes. By enabling efficient drug loading and precision targeting, this approach offers a promising strategy to enhance therapeutic efficacy while minimizing off-target toxicities, addressing a critical challenge in cancer treatment.
- 19 February 2025
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 13 (12) , 3945-3951
Amphiphilic lysine-based glycopeptides exert antibacterial effects on Pseudomonas aeruginosa
Glycomimetic antibacterial agents based on carbohydrate-lectin interactions were developed, which showed potent antibacterial activity against P. aeruginosa.
- 19 February 2025
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 13 (12) , 3945-3951
Amphiphilic lysine-based glycopeptides exert antibacterial effects on Pseudomonas aeruginosa
Glycomimetic antibacterial agents based on carbohydrate-lectin interactions were developed, which showed potent antibacterial activity against P. aeruginosa.
- 20 March 2024
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 67 (7) , 5945-5956
Amphiphilic α-Peptoid-deoxynojirimycin Conjugate-based Multivalent Glycosidase Inhibitor for Hypoglycemic Effect and Fluorescence Imaging
Multivalent glycosidase inhibitors based on 1-deoxynojirimycin derivatives against alpha-glucosidases have been rapidly developed. Nonetheless, the mechanism based on self-assembled multivalent glucosidase inhibitors in living systems needs to be further studied. It remains to be determined whether the self-assembly possesses sufficient stability to endure transit through the small intestine and subsequently bind to the glycosidases located therein. In this paper, two amphiphilic compounds, 1-deoxynojirimycin and alpha-peptoid conjugates (LP-4DNJ-3C and LP-4DNJ-6C), were designed. Their self-assembling behaviors, multivalent alpha-glucosidase inhibition effect, and fluorescence imaging on living organs were studied. LP-4DNJ-6C exhibited better multivalent alpha-glucosidase inhibition activities in vitro. Moreover, the self-assembly of LP-4DNJ-6C could effectively form a complex with Nile red. The complex showed fluorescence quenching effect upon binding with alpha-glucosidases and exhibited potent fluorescence imaging in the small intestine. This result suggests that a multivalent hypoglycemic effect achieved through self-assembly in the intestine is a viable approach, enabling the rational design of multivalent hypoglycemic drugs.
- 20 March 2024
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 67 (7) , 5945-5956
Amphiphilic α-Peptoid-deoxynojirimycin Conjugate-based Multivalent Glycosidase Inhibitor for Hypoglycemic Effect and Fluorescence Imaging
Multivalent glycosidase inhibitors based on 1-deoxynojirimycin derivatives against alpha-glucosidases have been rapidly developed. Nonetheless, the mechanism based on self-assembled multivalent glucosidase inhibitors in living systems needs to be further studied. It remains to be determined whether the self-assembly possesses sufficient stability to endure transit through the small intestine and subsequently bind to the glycosidases located therein. In this paper, two amphiphilic compounds, 1-deoxynojirimycin and alpha-peptoid conjugates (LP-4DNJ-3C and LP-4DNJ-6C), were designed. Their self-assembling behaviors, multivalent alpha-glucosidase inhibition effect, and fluorescence imaging on living organs were studied. LP-4DNJ-6C exhibited better multivalent alpha-glucosidase inhibition activities in vitro. Moreover, the self-assembly of LP-4DNJ-6C could effectively form a complex with Nile red. The complex showed fluorescence quenching effect upon binding with alpha-glucosidases and exhibited potent fluorescence imaging in the small intestine. This result suggests that a multivalent hypoglycemic effect achieved through self-assembly in the intestine is a viable approach, enabling the rational design of multivalent hypoglycemic drugs.
- 11 July 2023
- Published by Royal Society of Chemistry (RSC) in Materials Chemistry Frontiers
- Vol. 7 (21) , 5263-5287
Carbohydrate–macrocycle conjugates for biomedical applications
We summarized the development of macrocycle-carbohydrate conjugates and their biomedical application in the past decade, and provided our contention regarding the future trend of this topic.
- 11 July 2023
- Published by Royal Society of Chemistry (RSC) in Materials Chemistry Frontiers
- Vol. 7 (21) , 5263-5287
Carbohydrate–macrocycle conjugates for biomedical applications
We summarized the development of macrocycle-carbohydrate conjugates and their biomedical application in the past decade, and provided our contention regarding the future trend of this topic.
- 1 April 2021
- Published by Wiley in International Journal of Quantum Chemistry
- Vol. 121 (15) , e26667
H2 promoting effect in Cr/PNP‐catalyzed ethylene tetramerization: A density functional theory study
It is well known that hydrogen promotes catalyst activity in Cr/PNP‐catalyzed ethylene tetramerization, but the mechanism of this effect is unclear. A density functional theory (DFT) study was conducted to explore this effect, and conformation changes were carefully taken into consideration to build a clear reaction pathway. Three components in the ethylene tetramerization catalytic cycle were examined in detail: the production of 1‐hexene from metallacycloheptane, the production of 1‐octene from metallacyclononane, and the formation of an active centre on the Cr/PNP catalyst. This result indicates that the formation of an active centre on the catalyst becomes more favorable upon the imposition of hydrogen, where hydrogen functions as a second ligand. This easing effect could be the key factor leading to the outperformed Cr/PNP catalyst activity in ethylene tetramerization.
- 1 April 2021
- Published by Wiley in International Journal of Quantum Chemistry
- Vol. 121 (15) , e26667
H2 promoting effect in Cr/PNP‐catalyzed ethylene tetramerization: A density functional theory study
It is well known that hydrogen promotes catalyst activity in Cr/PNP‐catalyzed ethylene tetramerization, but the mechanism of this effect is unclear. A density functional theory (DFT) study was conducted to explore this effect, and conformation changes were carefully taken into consideration to build a clear reaction pathway. Three components in the ethylene tetramerization catalytic cycle were examined in detail: the production of 1‐hexene from metallacycloheptane, the production of 1‐octene from metallacyclononane, and the formation of an active centre on the Cr/PNP catalyst. This result indicates that the formation of an active centre on the catalyst becomes more favorable upon the imposition of hydrogen, where hydrogen functions as a second ligand. This easing effect could be the key factor leading to the outperformed Cr/PNP catalyst activity in ethylene tetramerization.